Screener
Travere Therapeutics, Inc. TVTX Free cash flow
Discontinued — last reported Q3 '24
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed October 30, 2025. Open the filing →
- Filed
- Oct 30, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001438533-25-000056
FAQ
- What is Travere Therapeutics, Inc.'s free cash flow?
- Travere Therapeutics, Inc. (TVTX) reported free cash flow of -$42.51M in Q3 2024.
- How has Travere Therapeutics, Inc.'s free cash flow changed year-over-year?
- Travere Therapeutics, Inc.'s free cash flow increased by 28.1% year-over-year, from -$59.14M to -$42.51M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Travere Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude